Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 1-2/2012

01-06-2012 | NON-THEMATIC REVIEW

Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance

Author: David Tarin

Published in: Cancer and Metastasis Reviews | Issue 1-2/2012

Login to get access

Abstract

This article provides a broad overview of the field of inappropriate gene expression in many organisms across the animal and plant kingdoms as well as its importance to human disease in general and cancer in particular. Study of the topic is especially important for understanding how the chaotic maelstrom of evolving and cascading regulatory genetic interactions in an advancing cancer produces its clinical effects and for designing pragmatic solutions to how such disorder might eventually be tamed. It is emphasized that the topic warrants much more attention in research and in clinical practice because of the added value it brings to refining cancer diagnosis and treatment and to the assessment of prognostic markers. It is also particularly relevant to understanding the etiology and extensive clinical manifestations of paraneoplastic syndromes affecting multiple organs remote from the tumor and the treatment or amelioration of the substantial morbidity that they cause in cancer patients. More broadly, inappropriate expression can be caused by a number of mechanisms including mutations, rearrangements of the genome, and viral insertions and, under prolonged selection pressures, also has the potential to be an agent of evolutionary change.
Literature
1.
Wood, I. C., Gray, N. K., & Jones, L. (2009). Gene expression in neuronal disease. Biochemical Society Transactions, 37(Pt 6), 1261–1262.PubMedCrossRef
2.
Suzuki, M., & Tarin, D. (2007). Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications. Molecular Oncology, 1(2), 172–180.PubMedCrossRef
3.
Montel, V., Suzuki, M., Galloy, C., Mose, E. S., & Tarin, D. (2009). Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation, 78(5), 283–291.PubMedCrossRef
4.
Montel, V., Huang, T. Y., Mose, E., Pestonjamasp, K., & Tarin, D. (2005). Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. American Journal of Pathology, 166(5), 1565–1579.PubMedCrossRef
5.
Agarwal, D., Goodison, S., Nicholson, B., Tarin, D., & Urquidi, V. (2003). Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation, 71(2), 114–125.PubMedCrossRef
6.
Heppner, G. H. (1984). Tumor heterogeneity. Cancer Research, 44(6), 2259–2265.PubMed
7.
Kruger, S., Thorns, C., Bohle, A., & Feller, A. C. (2003). Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. International Urology and Nephrology, 35(2), 169–173.PubMedCrossRef
8.
Fidler, I. J. (1978). Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Research, 38(9), 2651–2660.PubMed
9.
Tarin, D. (1976). Cellular interactions in neoplasia. In L. Weiss (Ed.), Fundamental aspects of metastasis (pp. 151–187). Amsterdam: North Holland.
10.
Tarin, D. (1972). Morphological studies on the mechanism of carcinogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 227–289). London: Academic.
11.
Tarin, D. (1967). Sequential electron microscopical study of experimental mouse skin carcinogenesis. International Journal of Cancer, 2(3), 195–211.CrossRef
12.
Tarin, D. (1969). Fine structure of murine mammary tumours: The relationship between epithelium and connective tissue in neoplasms induced by various agents. British Journal of Cancer, 23(2), 417–425.PubMedCrossRef
13.
Tarin, D. (1972). Tissue interactions in carcinogenesis. London: Academic.
14.
Tarin, D. (1968). Further electron microscopic studies on the mechanism of carcinogenesis: The specificity of the changes in carcinogen-treated mouse skin. International Journal of Cancer, 3(6), 734–742.CrossRef
15.
Tarin, D., & Croft, C. B. (1970). Ultrastructural studies of wound healing in mouse skin. II. Dermo-epidermal interrelationships. Journal of Anatomy, 106(Pt 1), 79–91.PubMed
16.
Matsumura, Y., & Tarin, D. (1992). Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340(8827), 1053–1058.PubMedCrossRef
17.
Matsumura, Y., Sugiyama, M., Matsumura, S., et al. (1995). Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. The Journal of Pathology, 177(1), 11–20.PubMedCrossRef
18.
Tarin, D., Hoyt, B. J., & Evans, D. J. (1982). Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. British Journal of Cancer, 46(2), 266–278.PubMedCrossRef
19.
Shields, S. E., Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Degradation of basement membrane collagens by metalloproteases released by human, murine and amphibian tumours. The Journal of Pathology, 143(3), 193–197.PubMedCrossRef
20.
Ogilvie, D. J., Hailey, J. A., Juacaba, S. F., Lee, E. C., & Tarin, D. (1985). Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. Journal of the National Cancer Institute, 74(1), 19–27.PubMed
21.
Ogilvie, D. J., McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent elaboration of collagenase by the renal adenocarcinoma of the leopard frog, Rana pipiens. Cancer Research, 44(8), 3438–3441.PubMed
22.
Bao, L., Pigott, R., Matsumura, Y., Baban, D., & Tarin, D. (1993). Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines. Differentiation, 52(3), 239–246.PubMedCrossRef
23.
Cailleau, R., Olive, M., & Cruciger, Q. V. (1978). Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro, 14(11), 911–915.PubMedCrossRef
24.
Urquidi, V., Sloan, D., Kawai, K., et al. (2002). Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical Cancer Research, 8(1), 61–74.PubMed
25.
Goodison, S., Kawai, K., Hihara, J., et al. (2003). Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clinical Cancer Research, 9(10 Pt 1), 3808–3814.PubMed
26.
Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004). Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Research, 64(5), 1687–1694.PubMedCrossRef
27.
Montel, V., Mose, E. S., & Tarin, D. (2006). Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. International Journal of Cancer, 119(2), 251–263.CrossRef
28.
Suzuki, M., Mose, E., Galloy, C., & Tarin, D. (2007). Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. American Journal of Pathology, 171(2), 682–692.PubMedCrossRef
29.
Suzuki, M., Mose, E. S., Montel, V., & Tarin, D. (2006). Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. American Journal of Pathology, 169(2), 673–681.PubMedCrossRef
30.
Ross, D. T., Scherf, U., Eisen, M. B., et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nature Genetics, 24(3), 227–235.PubMedCrossRef
31.
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007). MDA-MB-435 cells are derived from M14 melanoma cells—A loss for breast cancer, but a boon for melanoma research. Breast Cancer Research and Treatment, 104(1), 13–19.PubMedCrossRef
32.
Jessani, N., Liu, Y., Humphrey, M., & Cravatt, B. F. (2002). Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proceedings of the National Academy of Sciences of the United States of America, 99(16), 10335–10340.PubMedCrossRef
33.
Ellison, G., Klinowska, T., Westwood, R. F., Docter, E., French, T., & Fox, J. C. (2002). Further evidence to support the melanocytic origin of MDA-MB-435. Molecular Pathology, 55(5), 294–299.PubMedCrossRef
34.
Chambers, A. F. (2009). MDA-MB-435 and M14 cell lines: Identical but not M14 melanoma? Cancer Research, 69(13), 5292–5293.PubMedCrossRef
35.
Sellappan, S., Grijalva, R., Zhou, X., et al. (2004). Lineage infidelity of MDA-MB-435 cells: Expression of melanocyte proteins in a breast cancer cell line. Cancer Research, 64(10), 3479–3485.PubMedCrossRef
36.
Braun, A. C. (1981). An epigenetic model for the origin of cancer. The Quarterly Review of Biology, 56(1), 33–60.PubMedCrossRef
37.
Warr, G. (1981). The evolution of the lymphocyte. Immunology Today, 2, 63–68.CrossRef
38.
39.
Attwood, H. D., & Park, W. W. (1961). Embolism to the lungs by trophoblast. The Journal of Obstetrics and Gynaecology of the British Commonwealth, 68, 611–617.PubMedCrossRef
40.
Carstens, P. H. (1969). Pulmonary bone marrow embolism following external cardiac massage. Acta Pathologica et Microbiologica Scandinavica, 76(4), 510–514.PubMedCrossRef
41.
Muller, A., Homey, B., Soto, H., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410(6824), 50–56.PubMedCrossRef
42.
Zeelenberg, I. S., Ruuls-Van Stalle, L., & Roos, E. (2003). The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Research, 63(13), 3833–3839.PubMed
43.
Gunthert, U., Hofmann, M., Rudy, W., et al. (1991). A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65(1), 13–24.PubMedCrossRef
44.
Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M., & Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63(4), 887–892.PubMed
45.
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001). Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America, 98(6), 3352–3357.PubMedCrossRef
46.
Borsig, L., Wong, R., Hynes, R. O., Varki, N. M., & Varki, A. (2002). Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proceedings of the National Academy of Sciences of the United States of America, 99(4), 2193–2198.PubMedCrossRef
47.
Kim, Y. J., Borsig, L., Varki, N. M., & Varki, A. (1998). P-selectin deficiency attenuates tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9325–9330.PubMedCrossRef
48.
Matsuura, N., Puzon-McLaughlin, W., Irie, A., Morikawa, Y., Kakudo, K., & Takada, Y. (1996). Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. American Journal of Pathology, 148(1), 55–61.PubMed
49.
Langley, R. R., Carlisle, R., Ma, L., Specian, R. D., Gerritsen, M. E., & Granger, D. N. (2001). Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation, 8(5), 335–345.PubMed
50.
Ruoslahti, E., & Rajotte, D. (2000). An address system in the vasculature of normal tissues and tumors. Annual Review of Immunology, 18, 813–827.PubMedCrossRef
51.
McMenamin, M. M., Hayle, A. J., Darling, D. L., et al. (1988). Genetic basis of metastases. Advances in Experimental Medicine and Biology, 233, 269–279.PubMed
52.
Boyer, B., Tucker, G. C., Valles, A. M., Gavrilovic, J., & Thiery, J. P. (1989). Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. International Journal of Cancer. Supplement, 4, 69–75.CrossRef
53.
Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E. (2008). Epithelial–mesenchymal transition. Cancer Research, 68(23), 9574–9577.PubMedCrossRef
54.
Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial–mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420–1428.PubMedCrossRef
55.
Taube, J. H., Herschkowitz, J. I., Komurov, K., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15449–15454.PubMedCrossRef
56.
Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews. Cancer, 9(4), 265–273.PubMedCrossRef
57.
Tarin, D. (2005). The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Research, 65(14), 5996–6000.PubMedCrossRef
58.
Osterreicher, C. H., Penz-Osterreicher, M., Grivennikov, S. I., et al. (2011). Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proceedings of the National Academy of Sciences of the United States of America, 108(1), 308–313.PubMedCrossRef
59.
Humphreys, B. D., Lin, S. L., Kobayashi, A., et al. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. American Journal of Pathology, 176(1), 85–97.PubMedCrossRef
60.
Spemann, H. (1938). Embryonic induction and development. New Haven, CT: Yale University Press.
61.
Grobstein, C. (1953). Morphogenetic interaction between embryonic mouse tissues separated by a membrane filter. Nature, 172(4384), 869–870.PubMedCrossRef
62.
Kratochwil, K. (1972). Tissue interaction during embryonic development. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 1–47). London: Academic.
63.
Saxén, L. (1972). Interactive mechanisms in morphogenesis. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 49–80). London: Academic.
64.
Tarin, D. (1972). Tissue interactions in morphogenesis, morphostasis and carcinogenesis. Journal of Theoretical Biology, 34(1), 61–72.PubMedCrossRef
65.
Tarin, D. (1972). Tissue interactions and the maintenance of histological structure in adults. In D. Tarin (Ed.), Tissue interactions in carcinogenesis (pp. 81–93). London: Academic.
66.
Tarin, D., Price, J. E., Kettlewell, M. G., Souter, R. G., Vass, A. C., & Crossley, B. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Research, 44(8), 3584–3592.PubMed
67.
Tarin, D., & Price, J. E. (1981). Influence of microenvironment and vascular anatomy on “metastatic” colonization potential of mammary tumors. Cancer Research, 41(9 Pt 1), 3604–3609.PubMed
68.
Tarin, D. (2006). New insights into the pathogenesis of breast cancer metastasis. Breast Disease, 26, 13–25.PubMed
69.
Hart, I. R., & Fidler, I. J. (1980). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research, 40(7), 2281–2287.PubMed
70.
Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., & Fidler, I. J. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Research, 48(23), 6863–6871.PubMed
71.
Naito, S., von Eschenbach, A. C., Giavazzi, R., & Fidler, I. J. (1986). Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Research, 46(8), 4109–4115.PubMed
72.
Lucke, B. (1938). Carcinoma in the leopard frog: Its probable causation by a virus. The Journal of Experimental Medicine, 68(4), 457–468.PubMedCrossRef
73.
Lucke, B., & Schlumberger, H. (1949). Induction of metastasis of frog carcinoma by increase of environmental temperature. The Journal of Experimental Medicine, 89(3), 269–278.PubMedCrossRef
74.
McKinnell, R. G., & Tarin, D. (1984). Temperature-dependent metastasis of the Lucke renal carcinoma and its significance for studies on mechanisms of metastasis. Cancer and Metastasis Reviews, 3(4), 373–386.PubMedCrossRef
75.
Sugino, T., Gorham, H., Yoshida, K., et al. (1996). Progressive loss of CD44 gene expression in invasive bladder cancer. American Journal of Pathology, 149(3), 873–882.PubMed
76.
Sugino, T., Yoshida, K., Zhao, S., Goodison, S., & Tarin, D. (1998). Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions. The Journal of Pathology, 186(1), 17–23.PubMedCrossRef
77.
Tarin, D. (2011). Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Seminars in Cancer Biology, 21, 72–82.PubMedCrossRef
78.
Macaulay, V. M., & Smith, J. E. (1996). Paraneoplastic syndromes. In M. Peckham, H. M. Pinedo, & U. Veronesi (Eds.), Oxford textbook of oncology (pp. 2228–2253). Oxford: Oxford University Press.
79.
Lucke, B., & Berwick, M. (1954). Catalase activity of liver and kidney in frogs with spontaneous renal carcinoma. The Journal of Experimental Medicine, 100(2), 125–133.PubMedCrossRef
80.
Feng, W., McCabe, N. P., Mahabeleshwar, G. H., Somanath, P. R., Phillips, D. R., & Byzova, T. V. (2008). The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. The Journal of Cell Biology, 183(6), 1145–1157.PubMedCrossRef
81.
Carotta, S., Holmes, M. L., Pridans, C., & Nutt, S. L. (2006). Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation. Cell Cycle, 5(21), 2452–2456.PubMedCrossRef
82.
Miyamoto, T., & Akashi, K. (2005). Lineage promiscuous expression of transcription factors in normal hematopoiesis. International Journal of Hematology, 81(5), 361–367.PubMedCrossRef
83.
Caretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004). The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes & Development, 18(21), 2627–2638.CrossRef
84.
Mayer, R., Raventos, D., & Chua, N. H. (1996). det1, cop1, and cop9 mutations cause inappropriate expression of several gene sets. The Plant Cell, 8(11), 1951–1959.PubMedCrossRef
85.
Lamprecht, B., Walter, K., Kreher, S., et al. (2010). Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nature Medicine, 16(5), 571–579.PubMedCrossRef
86.
Engel, M. E., & Hiebert, S. W. (2010). The enemy within: Dormant retroviruses awaken. Nature Medicine, 16(5), 517–518.PubMedCrossRef
87.
Mueller, J., Gazzoli, I., Bandipalliam, P., Garber, J. E., Syngal, S., & Kolodner, R. D. (2009). Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Research, 69(17), 7053–7061.PubMedCrossRef
88.
Moura Lima, E., Ferreira Leal, M., Cardoso Smith Mde, A., et al. (2008). DNA mismatch repair gene methylation in gastric cancer in individuals from northern Brazil. Biocell, 32(3), 237–243.PubMed
89.
Thon, N., Eigenbrod, S., Grasbon-Frodl, E. M., et al. (2011). Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. Journal of Neurology, Neurosurgery, and Psychiatry, 82, 441–446.PubMedCrossRef
90.
Lahtz, C., & Pfeifer, G. P. (2011). Epigenetic changes of DNA repair genes in cancer. Journal of Molecular Cell Biology, 3(1), 51–58.PubMedCrossRef
91.
Villarreal, L. P., & Witzany, G. (2010). Viruses are essential agents within the roots and stem of the tree of life. Journal of Theoretical Biology, 262(4), 698–710.PubMedCrossRef
92.
Kennedy, J. F. (1962). Speech to Rice University on the launching of the moon landing program, 9th December 1962.
Metadata
Title
Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance
Author
David Tarin
Publication date
01-06-2012
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 1-2/2012
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-011-9326-8

Other articles of this Issue 1-2/2012

Cancer and Metastasis Reviews 1-2/2012 Go to the issue

NON-THEMATIC REVIEW

Role of parathymic lymph nodes in metastatic tumor development

NON-THEMATIC REVIEW

The genetic/metabolic transformation concept of carcinogenesis

NON-THEMATIC REVIEW

A new hypothesis for the cancer mechanism

NON-THEMATIC REVIEW

Potential roles for prions and protein-only inheritance in cancer

NON-THEMATIC REVIEW

Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration

NON-THEMATIC REVIEW

EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits